GDXRF Stock News 0.0530 05/08/2014 22:58:31 Goldex Resources

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Goldex Resources Cp (GDXRF) 0.0530 $GDXRF

HF, NEWT, GDX, CCO, LFUS, MFB Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jun 03, 5:22AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Hanfeng Evergreen Inc (NYSE:HF), Newtek Business Services Inc (NASDAQ:NEWT), Goldex Resources Corp (NYSE:GDX), Cameco Corp (NYSE:CCO), Littelfuse Inc (NASDAQ:LFUS), Maidenform Brands Inc (NYSE:MFB) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

IBKR, DCT, INP, MELA, GDX, HWCC Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Apr 24, 6:57AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of INTERACTIVE BROKERS GROUP, INC. (NASDAQ:IBKR), DCT Industrial Trust Inc (NYSECT), IPATH MSCI INDIA INDEX ETN (NYSE:INP), MELA Sciences Inc (NASDAQ:MELA), Goldex Resources Corp (NYSE:GDX), Houston Wire & Cable Co (NASDAQ:HWCC) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ARSD, CYNO, CROX, GDX, SAIA, BPZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jan 18, 6:00AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Arabian American Development Co (NASDAQ:ARSD), CYNOSURE INC (NASDAQ:CYNO), Crocs Inc (NASDAQ:CROX), Goldex Resources Corp (NYSE:GDX), Saia Inc (NASDAQ:SAIA), BPZ Resources Inc (NYSE:BPZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

MGEE, KS, BAS, POR, USO, GDX Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Thu Dec 20, 6:10AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of MGE Energy Inc (NASDAQ:MGEE), KapStone Paper and Packaging Corp (NYSE:KS), Basic Energy Services Inc (NYSE:BAS), Portland General Electric Co (NYSEOR), US Oil Sands Inc (NYSE:USO), Goldex Resources Corp (NYSE:GDX) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading

Top 5 Most Recently Viewed Articles

Southwire Unveils 2025 Sustainability Report: Changes Ahead

Updated Category News Views 9

Southwire's Bold Sustainability Vision for the Future Southwire's latest foray into sustainability leaves me chewing over a whole new set of ambitious targets. As the veteran player in North America's wire and cable scene, they're not just running the presses—they're mapping the future with grand gestures. July 30, 2026, marks their announcement of the 2025...

Continue Reading
Wells Fargo to Share Insights on Q4 2024 Earnings Call Soon

Updated Category News Views 267

Wells Fargo Announces Upcoming Earnings Report Wells Fargo & Company (NYSE: WFC) is set to reveal its fourth quarter earnings for 2024 on January 15. This anticipated announcement is scheduled to be shared around 7:00 a.m. Eastern time, allowing investors and financial enthusiasts to gain crucial insights into the company's financial performance and strategic direction....

Continue Reading
Peter Schiff Challenges Tariff Ruling as Inflation Cools

Updated Category News Views 300

Breaking Down Schiff’s Take on Trade Look, this whole talk about foreign countries ripping off America? It’s a bunch of hot air, if you ask me. Peter Schiff, that famous economist who’s always got something to say, slammed that narrative recently. Ya know, he's making waves on X, saying, "No country has been ripping off America." I mean, he's basically flipping the...

Continue Reading
LifeMD's Financial Growth Highlights and Strategic Outlook

Updated Category News Views 200

LifeMD Reports Impressive Financial Growth LifeMD, Inc. (NASDAQ: LFMD), a prominent virtual healthcare provider, has showcased remarkable resilience in its third-quarter financial results for the year. The company's total revenue has surged by 13% year-over-year, reaching $60.2 million, with adjusted EBITDA rising significantly by 20%, totaling $5.1 million. These results...

Continue Reading
Intellia Therapeutics Investors Explore Legal Options for Rights

Updated Category News Views 188

Understanding the Class Action for Intellia Therapeutics As an investor in Intellia Therapeutics, Inc. (NASDAQ: NTLA), staying informed is vital, especially regarding your legal rights. Recently, the Rosen Law Firm, a notable player in the investor rights landscape, has issued reminders about a critical upcoming deadline concerning a class action lawsuit aimed at the...

Continue Reading